Patients
cataract, PD, dry eye disease
CATARACT
Forty-six patients to undergo planned cataract surgery with absent or mild dry eye disease were randomly assigned to receive either nonpreserved (PFD group) or preserved (PD group) dexamethasone eye drops in postoperative treatment. Six patients were lost to follow-up, leaving 20 patients in each group, with 9 left eyes and 11 right eyes in each group. Seventeen patients (80%) in the PFD group and 12 (60%) patients in the PD group were female. The mean ages in the PFD and PD groups were 68 ± 6.7 and 65 ± 9.1 years, respectively (p = 0.37). No statistically significant differences in baseline subjective and objective assessments were observed between the PFD and PD groups (Table Baseline clinical characteristics in the PFD group (preservative-free dexamethasone) and PD group (preserved dexamethasone) presented as the mean and standard deviation.*Mann–Whitney 